Article Text

other Versions

PDF
The use of laboratory biomarkers for surveillance, diagnosis and prediction of clinical outcomes in neonatal sepsis and necrotising enterocolitis 
  1. Pak Cheung Ng,
  2. Terence Ping Yuen Ma,
  3. Hugh Simon Lam
  1. Department of Paediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong
  1. Correspondence to Professor Pak Cheung Ng, Department of Paediatrics, Prince of Wales Hospital, 6th Floor, Lui Che Woo Clinical Sciences Building, Shatin, N.T., Hong Kong; pakcheungng{at}cuhk.edu.hk

Abstract

Biomarkers have been used to differentiate systemic neonatal infection and necrotising enterocolitis (NEC) from other non-infective neonatal conditions that share similar clinical features. With increasing understanding in biochemical characteristics of different categories of biomarkers, a specific mediator or a panel of mediators have been used in different aspects of clinical management in neonatal sepsis/NEC. This review focuses on how these biomarkers can be used in real-life clinical settings for daily surveillance, bedside point-of-care testing, early diagnosis and predicting the severity and prognosis of neonatal sepsis/NEC. In addition, with recent development of ‘multi-omic’ approaches and rapid advancement in knowledge of bioinformatics, more novel biomarkers and unique signatures of mediators would be discovered for diagnosis of specific diseases and organ injuries.

  • biomarkers
  • infants
  • infection
  • necrotising enterocolitis

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.